LOS ANGELES, CA / ACCESSWIRE / August 26, 2020 / Myomo, Inc. (NYSE American:MYO), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis today announced that it will be presenting at the LD 500 investor conference on Wednesday, September 2, 2020 at 11:00 a.m. EDT. Chairman and Chief Executive Officer Paul Gudonis and Chief Financial Officer David Henry will be presenting to a live virtual audience.
For the real-time presentation register here. In addition, a replay will be available on Myomo's website at this link.
"We have been waiting for this moment all year long. Due to COVID, it has been nearly impossible for physical conferences to even take place. I want to show the world that you can still learn, have a great time, and see some of the most unique companies in the capital markets today. All without having to step foot outside. For the first time, LD Micro is accessible to everyone, and we are honored to welcome you to one of the most trusted platforms in the space," stated Chris Lahiji, Founder of LD.
The LD 500 will take place on September 1st through the 4th.
View Myomo's profile here: http://www.ldmicro.com/profile/MYO
Profiles powered by LD Micro - News Compliments of Accesswire
About Myomo
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient's own EMG signals through non-invasive sensors on the arm, can restore an individual's ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S and representatives internationally. For more information, please visit www.myomo.com.
About LD Micro
Back in 2006, LD Micro began with the sole purpose of being an independent resource to the microcap world.
What started as a newsletter highlighting unique companies, has transformed into the pre-eminent event platform in the space.
The upcoming "500" in September is the Company's most ambitious project yet, and the first event that is accessible to everyone.
For those interested in attending, please contact David Scher at [email protected] or visit www.ldmicro.com for more information.
Contact:
For Myomo:
[email protected]
Investor Relations:
Kim Sutton Golodetz
LHA Investor Relations
[email protected]
212-838-3777
Public Relations:
Kate McCann
Matter Communications
[email protected]
SOURCE: Myomo, Inc. via LD Micro